Come up with a name for your new list and we'll add to it:
EnBiotix raised a round of funding on May 26, 2016. Investors include
Grand Challenges Explorations.
EnBiotix is an engineered antibiotics company deploying novel systems and synthetic biology technologies developed by Prof. James J. Collins, the Termeer Professor of Medical Engineering & Science Pro…